329 related articles for article (PubMed ID: 19285635)
41. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
[TBL] [Abstract][Full Text] [Related]
42. A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
Fong T; Trinkaus K; Adkins D; Vij R; Devine SM; Tomasson M; Goodnough LT; Lopez S; Graubert T; Shenoy S; Dipersio JF; Khoury HJ
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1201-6. PubMed ID: 17889357
[TBL] [Abstract][Full Text] [Related]
43. Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback.
Chakrabarti S; Brown J; Guttridge M; Pamphilon DH; Lankester A; Marks DI
Bone Marrow Transplant; 2003 Jul; 32(1):23-30. PubMed ID: 12815474
[TBL] [Abstract][Full Text] [Related]
44. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
45. Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study.
Kataoka K; Nannya Y; Ueda K; Kumano K; Takahashi T; Kurokawa M
Bone Marrow Transplant; 2010 Mar; 45(3):513-20. PubMed ID: 19684632
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD.
Kim DH; Sohn SK; Jeon SB; Baek JH; Kim JG; Lee NY; Suh JS; Lee KB; Shin IH
Bone Marrow Transplant; 2006 Jan; 37(1):101-8. PubMed ID: 16258533
[TBL] [Abstract][Full Text] [Related]
47. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
Elmaagacli AH; Koldehoff M; Hindahl H; Steckel NK; Trenschel R; Peceny R; Ottinger H; Rath PM; Ross RS; Roggendorf M; Grosse-Wilde H; Beelen DW
Transplantation; 2006 Jan; 81(2):247-54. PubMed ID: 16436969
[TBL] [Abstract][Full Text] [Related]
48. Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset.
Moon JH; Kim SN; Kang BW; Chae YS; Kim JG; Ahn JS; Kim YK; Yang DH; Lee JJ; Kim HJ; Choi YJ; Shin HJ; Chung JS; Cho GJ; Sohn SK
Bone Marrow Transplant; 2010 Oct; 45(10):1540-5. PubMed ID: 20190848
[TBL] [Abstract][Full Text] [Related]
49. Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
Kyriakou C; Canals C; Finke J; Kobbe G; Harousseau JL; Kolb HJ; Novitzky N; Goldstone AH; Sureda A; Schmitz N
J Clin Oncol; 2009 Aug; 27(24):3951-8. PubMed ID: 19620487
[TBL] [Abstract][Full Text] [Related]
50. Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.
Detrait M; Dubois V; Sobh M; Morisset S; Tedone N; Labussière H; Gillis L; Barraco F; Cannas G; Ducastelle S; Fatoum J; Thomas X; Chelgoum Y; Nicolini FE; Michallet M
Exp Hematol; 2012 Oct; 40(10):792-9. PubMed ID: 22705505
[TBL] [Abstract][Full Text] [Related]
51. To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors.
Parody R; Caballero D; Márquez-Malaver FJ; Vázquez L; Saldaña R; Madrigal MD; Calderón C; Carrillo E; Lopez-Corral L; Espigado I; Carmona M; López-Villar O; Pérez-Simón JA
Eur J Haematol; 2013 Nov; 91(5):448-55. PubMed ID: 23710624
[TBL] [Abstract][Full Text] [Related]
52. Adult allogeneic haematopoietic stem cell transplantation: a single centre experience in Malaysia.
Gan GG; Zakaria Z; Sangkar JV; Haris AR; Bee PC; Chin E; Teh A
Med J Malaysia; 2008 Oct; 63(4):281-7. PubMed ID: 19385485
[TBL] [Abstract][Full Text] [Related]
53. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633
[TBL] [Abstract][Full Text] [Related]
54. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation.
Kim DH; Kim JG; Sohn SK; Sung WJ; Suh JS; Lee KS; Lee KB
Br J Haematol; 2004 Apr; 125(2):217-24. PubMed ID: 15059145
[TBL] [Abstract][Full Text] [Related]
55. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
[TBL] [Abstract][Full Text] [Related]
56. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
57. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.
Shaw BE; Mufti GJ; Mackinnon S; Cavenagh JD; Pearce RM; Towlson KE; Apperley JF; Chakraverty R; Craddock CF; Kazmi MA; Littlewood TJ; Milligan DW; Pagliuca A; Thomson KJ; Marks DI; Russell NH
Bone Marrow Transplant; 2008 Dec; 42(12):783-9. PubMed ID: 18724393
[TBL] [Abstract][Full Text] [Related]
58. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.
Min CK; Kim SY; Lee MJ; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC; Cho CS
Bone Marrow Transplant; 2006 Jul; 38(2):149-56. PubMed ID: 16751784
[TBL] [Abstract][Full Text] [Related]
59. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
[TBL] [Abstract][Full Text] [Related]
60. Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Norlin AC; Sairafi D; Mattsson J; Ljungman P; Ringdén O; Remberger M
Bone Marrow Transplant; 2008 Feb; 41(3):267-73. PubMed ID: 17994123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
